Publication Date
| In 2025 | 1 |
| Since 2024 | 1 |
| Since 2021 (last 5 years) | 1 |
| Since 2016 (last 10 years) | 1 |
| Since 2006 (last 20 years) | 2 |
Descriptor
Author
| Aman, Michael G. | 1 |
| Arnold, L. Eugene | 1 |
| Hollway, Jill A. | 1 |
| Irva Hertz-Picciotto | 1 |
| Jennie Sotelo-Orozco | 1 |
| Leone, Sarah | 1 |
| Lindsay, Ronald | 1 |
| Masty, Jessica | 1 |
| Nash, Patricia | 1 |
Publication Type
| Journal Articles | 2 |
| Reports - Research | 2 |
Education Level
Audience
Location
Laws, Policies, & Programs
Assessments and Surveys
| Aberrant Behavior Checklist | 2 |
| Mullen Scales of Early… | 1 |
| Vineland Adaptive Behavior… | 1 |
What Works Clearinghouse Rating
Peer reviewed
Direct linkJennie Sotelo-Orozco; Irva Hertz-Picciotto – Journal of Autism and Developmental Disorders, 2025
Investigate the association between gastrointestinal (GI) issues and psychometric scores among children with developmental delays and typical development. We examined the association between GI issues and the Mullen Scale of Early Learning (MSEL), Vineland Adaptive Behavior Subscales (VABS), and Aberrant Behavior Checklist (ABC) scores from…
Descriptors: Autism Spectrum Disorders, Physiology, Developmental Delays, Down Syndrome
Aman, Michael G.; Hollway, Jill A.; Leone, Sarah; Masty, Jessica; Lindsay, Ronald; Nash, Patricia; Arnold, L. Eugene – Research in Developmental Disabilities: A Multidisciplinary Journal, 2009
This study was designed to explore the placebo-controlled effects of risperidone on cognitive-motor processes, dyskinetic movements, and behavior in children receiving maintenance risperidone therapy. Sixteen children aged 4-14 years with disruptive behavior were randomly assigned to drug order in a crossover study of risperidone and placebo for 2…
Descriptors: Metabolism, Behavior Problems, Reaction Time, Hyperactivity
